Table 2.
Clinical parameters and treatment outcomes between IC and IC/IS group
| Characteristic | IC group(n=48) | IC/IS group(n=52) | p-value |
|---|---|---|---|
| Diameter of the tumor (cm) | |||
| ≤4 cm | 18 | 19 | 0.9 |
| >4 cm | 30 | 33 | |
| Tumor stage (FIGO stage) | |||
| IIB | 16 | 8 | 0.99 |
| IIIB | 29 | 41 | |
| IVA | 3 | 3 | |
| D2cc for OAR | |||
| Small bowel D2cc | 61.23±7.45 | 60.14±7.56 | 0.47 |
| Bladder D2cc | 72.02±8.27 | 73.58±8.06 | 0.34 |
| Rectum D 2cc | 73.55±6.54 | 71.84±6.69 | 0.20 |
| Bladder LSE | |||
| Grade 0-1 | 46 | 47 | 0.25 |
| Grade 2 | 2 | 5 | |
| Rectum LSE | |||
| Grade 0-1 | 25 | 35 | |
| Grade 2-3 | 23 | 17 | 0.09 |
| Overall treatment time (days) | |||
| <58 | 20 | 22 | |
| ≥58 | 28 | 30 | 0.9 |
| D90 | 79.96±10.45 | 89.29±10.9 | <0.01* |
| LC | 86.3% | 91.6% | 0.45 |